Abstract: The present disclosure provides a wearable component. The wearable component includes a first carrier and a first electronic component at least partially embedded within the first carrier. The first carrier and the first electronic component define a space configured for audio transmission. An ear tip and a method of manufacturing a wearable component are also provided.

Abstract: The present disclosure provides a wearable component. The wearable component includes a first carrier and a first electronic component at least partially embedded within the first carrier. The first carrier and the first electronic component define a space configured for audio transmission. An ear tip and a method of manufacturing a wearable component are also provided.

Abstract: A system for recognizing the location of a subject, comprises a server, signal transceivers, and a tracking device. The server transmits a request and stores a map file. The signal transceivers respectively communicate with the server to receive the request, and broadcast a reference signal to the other signal transceivers. The tracking device bidirectionally communicates with the signal transceivers, and periodically sends a tracking signal. After each of the signal transceivers obtains the first received signal strength indicator corresponding to the received reference signal and the second received signal strength indicator corresponding to the received tracking signal, each transmits the first signal strength indicator and the second signal strength indicator to the server.

Abstract: The present disclosure provides a wearable component. The wearable component includes a first carrier and a first electronic component at least partially embedded within the first carrier. The first carrier and the first electronic component define a space configured for audio transmission. An ear tip and a method of manufacturing a wearable component are also provided.

Abstract: A system for recognizing the location of a subject, comprises a server, signal transceivers, and a tracking device. The server transmits a request and stores a map file. The signal transceivers respectively communicate with the server to receive the request, and broadcast a reference signal to the other signal transceivers. The tracking device bidirectionally communicates with the signal transceivers, and periodically sends a tracking signal. After each of the signal transceivers obtains the first received signal strength indicator corresponding to the received reference signal and the second received signal strength indicator corresponding to the received tracking signal, each transmits the first signal strength indicator and the second signal strength indicator to the server.

Abstract: The invention relates to a method for enhancing wound healing in a subject in need thereof, comprising administering to the subject a composition comprising fibronectin type III domain-containing protein 5 (FNDC5) or its cleaved fragment irisin in an amount effective to enhance wound healing

Abstract: The invention discloses one immunoassay for aflatoxin-albumin adducts measurement in serum. In Particular, serum pretreatments including albumin precipitation, resuspension, dialysis, albumin digestion, enzyme precipitation and aflatoxin extraction, centrifugation and resuspension are unnecessary, which is convenient for clinical routine serum testing. The invention also discloses their clinical uses in rapid measurement of the doses of aflatoxin exposure, which is one of risk factors of liver cancer.

Abstract: The invention discloses one radioimmunoassay testing kit and method for detecting aflatoxin-albumin adducts. The radioimmunoassay testing kit combining with competitive inhibition radioimmunometric assay, could be used to quantitate the aflatoxin-albumin adducts in serum. The invention also discloses their clinical uses in rapid mass detection of the doses of aflatoxin exposure, which is one of risk factors of liver cancer.

Abstract: The invention discloses one radioimmunoassay testing kit and method for detecting aflatoxin-albumin adducts. The radioimmunoassay testing kit combining with competitive inhibition radioimmunometric assay, could be used to quantitate the aflatoxin-albumin adducts in serum. The invention also discloses their clinical uses in rapid mass detection of the doses of aflatoxin exposure, which is one of risk factors of liver cancer.